CD40 Ligand (CD154) Does Not Contribute to Lymphocyte-Mediated Inhibition of Virulent Mycobacterium tuberculosis within Human Monocytes
AUTOR(ES)
Larkin, Rhonda
FONTE
American Society for Microbiology
RESUMO
Human monocytes displayed increased expression of CD40 following infection with virulent Mycobacterium tuberculosis. Nevertheless, soluble CD40 ligand (CD40L; also designated CD154) had no effect on the intracellular growth of the organism. Restriction of the intracellular growth of M. tuberculosis by peripheral blood lymphocytes and antigen-specific CD4+ T-cell lines likewise was not reduced by blocking anti-CD40L monoclonal antibody 5c8.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=128186Documentos Relacionados
- Abnormal CD40 Ligand (CD154) Expression in Human Immunodeficiency Virus-Infected Children
- CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines
- Demonstration in Tissue Culture of Lymphocyte-Mediated Immunity to Tuberculosis
- CD4+ Lymphocyte-Mediated Suppression of Cytomegalovirus Expression in Human Astrocytes
- Lymphocyte-mediated immune cytotoxicity in dogs infected with virulent canine distemper virus.